Evaluation of the Cytotoxic Effects of Ciprofloxacin on Human Glioblastoma A-۱۷۲ Cell Line
محل انتشار: مجله سرطان خاورمیانه، دوره: 8، شماره: 3
سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 140
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MISJ-8-3_001
تاریخ نمایه سازی: 25 آبان 1402
چکیده مقاله:
Background: Glioblastoma multiforme, the most common, aggressive malignant brain tumor which affects patients of all ages, is principally resistant to treatment. Ciprofloxacin is an antibiotic that belongs to the fluoroquinolones. There are welldocumented observations which indicate that ciprofloxacin has substantial anti-proliferative, apoptotic, cytotoxic and oxidative stress activities on various tumor cell lines.Methods: We exposed the glioblastoma A-۱۷۲ cell line to ciprofloxacin for ۲۴, ۴۸ and ۷۲ h. Cytotoxicity was measured using MTT assay. The levels of Bax as an apoptotic and Bcl-۲ as an anti-apoptotic protein were measured by ELISA and oxidative stress by the malondialdehyde assay.Results: Ciprofloxacin induced tumor cell death in a dose-dependent manner with an IC۵۰ value of ۲۵۹.۳ μM at ۷۲ h. We observed an increase in Bax levels, a decrease in Bcl-۲ concentrations and increased Bax/Bcl-۲ ratio under the influence of ciprofloxacin. Malondialdehyde levels, as an important marker of oxidative stress, increased in the human glioblastoma A-۱۷۲ cell line.Conclusion: These results indicated that ciprofloxacin had anti-tumor, cytotoxic and apoptotic effects in the human glioblastoma A-۱۷۲ cell line which might be useful as an adjuvant added to a glioblastoma multiforme chemotherapeutic protocol in the future.
نویسندگان
Ashkan Zandi
Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Taraneh Moini Zanjani
Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Seyed Ali Ziai
Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Yalda Khazaei Poul
Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mostafa Haji Molla Hoseini
Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran